News | May 09, 2025
Agilent inaugurates India Solution Center to accelerate innovation
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
This outcome reflects Innoxel Lifesciences' ongoing commitment to maintaining the highest standards of quality, compliance, and regulatory excellence
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
The Q1 2025 also witnessed a successful launch of Allegra D
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
This approval authorizes the company to export Ibuprofen to the Chinese markets
Subscribe To Our Newsletter & Stay Updated
